Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
261 people get ENZN articles and Market Currents by email alert.
Get email alerts on ENZN »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
Marketwire (Mar 18, 2013)
-
-
-
-
-
-
Marketwire (Dec 17, 2012)
-
Marketwire (Nov 29, 2012)
-
Tracking Seth Klarman's Baupost Group Holdings - Q3 2012 UpdateJohn Vincent • Wed, Nov 14, 2012
-
Marketwire (Nov 8, 2012)
-
Marketwire (Oct 31, 2012)
-
Marketwire (Sep 11, 2012)
-
-
-
Marketwire (Aug 1, 2012)
To learn more about Seeking Alpha Pro, click here.
-
-
Anything Positive At Enzon?Suman Chatterjee • Sun, Sep 25, 2011 -
Enzon Pharmaceuticals: A Two-Platform CompanyJason Chew • Tue, Dec 21, 2010 -
-
-
Enzon Shareholders Demand ChangeEben Tessari • Wed, May 21, 2008 -
-
-
Carl Icahn Boosts Stake in Enzon PharmLon Juricic • Mon, Mar 17, 2008
-
-
-
-
-
-
-
-
-
-
Tracking Seth Klarman's Baupost Group Holdings - Q3 2012 UpdateJohn Vincent • Wed, Nov 14, 2012
-
-
-
-
-
-
4 Highly Liquid Biotech Stocks With Bullish Short TrendsKapitall • Thu, May 10, 2012 -
-
-
-
-
-
Enzon Pharmaceuticals, Inc. Q1 2010 Earnings Call TranscriptMon, May 10, 2010
-
Enzon Pharmaceuticals, Inc. Q2 2008 Earnings Call TranscriptMon, Aug 11, 2008
-
Enzon Pharmaceuticals Inc., Q1 2008 Earnings Call TranscriptWed, May 7, 2008
-
Marketwire (Mar 18, 2013)
-
at CNBC.com (Dec 17, 2012)
-
at CNBC.com (Dec 17, 2012)
-
at CNBC.com (Dec 17, 2012)
-
Marketwire (Dec 17, 2012)
-
Marketwire (Nov 29, 2012)
-
Marketwire (Nov 8, 2012)
-
Marketwire (Oct 31, 2012)
-
Marketwire (Sep 11, 2012)
-
Marketwire (Aug 1, 2012)
-
Marketwire (May 2, 2012)
-
Marketwire (Mar 12, 2012)
-
at MarketWatch.com (Sep 23, 2011)
-
at CNBC.com (Aug 10, 2011)
ENZN vs. ETF Alternatives
Company Description
We are a biopharmaceutical company dedicated to developing, manufacturing and commercializing important medicines for patients with cancer and other life-threatening conditions. We have a portfolio of four marketed products, Oncaspar®, DepoCyt®, Abelcet® and Adagen®. Our drug development... More
-
MagicDiligence
Also new to the Magic Formula is Enzon Pharma $ENZN. Y! profile starts: "Enzon Pharmaceuticals, Inc. does not have significant operations." - View all 0 replies
-
- View all 3 replies
-
Ocean Man: Maybe, or you could go long ENZN and short MHH. But nothing's a sure thing.
-
-
Jim Van Meerten
ENZN - 60% Barchart technical sell signal - lost 7.90% in the last month - Relative Strength Index 34.59% - View all 0 replies
-
Jim Van Meerten
ENZN - 32% Barchart technical buy signal - 10 new hgihs and up 14.42% in the last month - Relative Strength Index 66.05% - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES
-
- View all 3 replies
-
Ocean Man: Maybe, or you could go long ENZN and short MHH. But nothing's a sure thing.
-